Slideshow
Author(s):
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Coupling Eye Movements and Postural Sway Significantly Enhances Stability in Parkinson Disease
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Huntington Agent SAGE-718 to be Discontinued Following Disappointing Phase 2 DIMENSION Trial Results
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Phase 3 ARISE Trial of Parkinson Therapy Solengepras Begins Dosing
This Week on NeurologyLive® — November 18, 2024